Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.

Drug-Induced Cognition Disorders in the Elderly: Incidence, Prevention and Management

Gray, Shelly L., Lai, Katie V., Larson, Eric B. · 1999 · Drug Safety

Abstract

The aetiology of cognitive impairment is multifactorial; however, drugs are an important cause of delirium and dementia. Several factors may increase the risk of drug-induced cognition disorders in the elderly including imbalances in neurotransmitters (e.g. acetylcholine), age-related alterations in pharmacokinetics and pharmacodynamics, and high levels of medication use. Nearly any drug can cause cognitive impairment in susceptible individuals; however, certain classes are more commonly implicated. Benzodiazepines, opioids, anticholinergics, and tricyclic antidepressants are probably the worst offenders. Older antihypertensive agents (reserpine, clonidine) have negative effects on cognition; however, large clinical trials in the elderly indicate that commonly used agents [e.g. thiazide diuretics, calcium antagonists (amiodipine, diltiazem), ACE inhibitors (captopril, enalapril) and beta-blockers (atenolol)] have minimal effects on cognition. Newer antidepressants such as selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors (SSRIs) and reversible inhibitors of monoamine oxidase A have not been shown to have negative effects on cognition. Although some drugs have shown low risk for causing cognition disorders in research studies, risk may be increased in frail older adults taking several medications and each case should be reviewed carefully. Identification of drug-induced cognitive impairment is crucial to early detection and resolution of symptoms. Preventive strategies directed at avoiding high risk medications when possible, appropriately adjusting doses based on age-related changes and close follow-up may prevent these conditions.

Overview

Integrity signals

Registry

Crossref · 10.2165/00002018-199921020-00004

Cites

156 of 156 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 153 references

Cited by

See all 211

Metadata

Authors
Gray, S. L., Lai, K. V., & Larson, E. B.
Affiliations
  • University of Washington (US)
  • Harborview Medical Center (US)
Corresponding author
Gray, Shelly L.
Venue
Drug Safety
Published
1999
Volume
21
Issue
2
Pages
101-122
ISSN
0114-5916 (ISSN-L)
OpenAlex
W2037309189
Cited by
190
References
153
Citations by year
2026: 4 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 6 · 2018: 6 · 2017: 1 · 2016: 9 · 2015: 5 · 2014: 4 · 2013: 6 · 2012: 9
FWCI
5.72
Type
journal article
Language
en
Open access
closed
Locations
  • Drug Safety (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
drug-induced cognitive impairment, delirium, dementia, older adults, benzodiazepines, opioids, anticholinergic agents, tricyclic antidepressants, age-related pharmacokinetics, polypharmacy, frail elderly, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, thiazide diuretics, calcium channel blockers, ACE inhibitors, beta-blockers, reserpine, clonidine, acetylcholine, cognitive impairment prevention
MeSH terms
Aged, Analgesics, Antidepressive Agents, Benzodiazepines, Delirium, Dementia, Humans, Risk Factors, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug-Induced Cognition Disorders in the Elderly: Incidence, Prevention and Management. https://app.cochat.ai/papers/10.2165/00002018-199921020-00004
The paper
Gray, S. L., Lai, K. V., & Larson, E. B. (1999). Drug-Induced Cognition Disorders in the Elderly: Incidence, Prevention and Management. Drug Safety. https://doi.org/10.2165/00002018-199921020-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.